Pharmacogenomics Fundamentals for Today's Clinicians - Online
Mayo Clinic and the Center for Individualized Medicine is working to close the gap between education and application of pharmacogenomics; made more prevalent by the increased access and affordability of genetic and pharmacogenomics test. This online content has been created to provide multidisciplinary education to those in a busy practice and not able to make it to one of the live CME courses offered.
Pharmacogenomics (PGx), the study of how one’s genes may affect an individual’s response to medication, is an emerging field within patient care. This course aims to prepare today’s clinician with the fundamentals of pharmacogenomics, including real-life case examples. Expert faculty provide the education needed to implement PGx into clinical practice.
Faculty
Timothy B. Curry, M.D., Ph.D. - Course Director | |
Garrett E. Schramm, Pharm.D., R.Ph. - Course Director Pharmacy Services | |
Richard Weinshilboum, M.D. | |
Ann M. Moyer, M.D., Ph.D. | |
John D. Zeuli, Pharm.D., R.Ph. |
Target Audience
This course is designed for Physicians, Physician Assistants, Nurse Practitioners, residents/fellow, Nurses, Pharmacists, Psychologists, Healthcare Executives.
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Explain foundational pharmacogenomics principles
- Describe the pharmacogenomics tests available for use and consideration in clinical practice
- Apply pharmacogenomics test results to make recommendations for an individualized medication management plan
Attendance at this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
Additional Information
Attachment | Size |
---|---|
Additional Course Information | 38.62 KB |
Accreditation Statement:
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACPE
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 2.0 ACPE knowledge-based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity.
2021 UAN: JA0000238-0000-21-068-H04-P
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.
Available Credit
- 2.00 ACPE
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Attendance
Price
Course includes the following:
Pharmacogenomics from Bench to Bedside Dr. Richard Weinshilboum, with over 40 years of research and clinical experience, sets the stage for this pharmacogenomics (PGx) course. He presents key, foundational principles, examples of early and current research, testing options and the trajectory of PGx in practice. | |
Pharmacogenomics Primer Pharmacogenomics (PGx) at the bedside is more than understanding drug-gene interactions. Dr. Zeuli explains foundational PGx concepts and how they apply to patient care. | |
Laboratory Aspects of Pharmacogenomics Explore the laboratory side of pharmacogenomics testing using applications in patient care:
| |
Case Module Pulling it all together, click through real-life cases and make decisions based on the key concepts learned earlier:
|
Cancellation and Refund Policy:
Request for cancellations must be submitted in writing to cme@mayo.edu.
Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.